Skip to content

AMS Evaluation Study

Evaluation Clinical Study Of The Ambulatory Monitoring Solution (AMS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04472208
Enrollment
34
Registered
2020-07-15
Start date
2021-02-26
Completion date
2021-10-14
Last updated
2021-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Monitoring

Brief summary

A study to evaluate the operational and functional features of the Ambulatory Monitor Solution (AMS) as well as the ease of use of the system.

Detailed description

The study is going to be conducted to collect feedback from the users about operation of AMS collect parameter raw data from patients in hospital ward setting using the investigational system for use in current and future AMS engineering and regulatory purposes as deemed appropriate by the Sponsor.

Interventions

Subjects participating in this study will be monitored with the site's standard of care primary monitor and the evaluable device as the secondary monitor.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female aged 18 years or older (≥18 years); 2. Able and willing to provide written informed consent independently.

Exclusion criteria

1. Have previously participated in this study (no subject may participate more than once); 2. Have an implantable pacemaker; 3. Diagnosed with infection requiring isolation; OR 4. Known to be pregnant and/or breast feeding;

Design outcomes

Primary

MeasureTime frameDescription
User feedback survey about the use of the Ambulatory Monitoring Solution5 daysThe feedback from the clinical users about operational features, alarms, user experience and ease of use of Ambulatory Monitoring Solution will be collected.

Other

MeasureTime frameDescription
Collect number of adverse events (AEs), serious adverse events (SAEs), and device issues1 yearThe safety objective is to collect safety information, including type and number of adverse events (AE), serious adverse events (SAE), and device issues. The descriptive statistical methods will be used to analyze AE and SAE data.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026